Marijuana Companies — Buying Stock In

: Rescheduling to Schedule III would eliminate Section 280E of the tax code, allowing U.S. cannabis companies to deduct standard business expenses and potentially saving the industry over $2 billion in taxes annually.

Investing in marijuana companies in 2026 is driven by two primary factors: fundamental and regulatory shifts , specifically the rescheduling of cannabis to Schedule III. While the sector has seen a historical valuation drop of nearly 90% over the past five years, these lower entry prices may offer bargain-hunting opportunities for long-term investors. Strategic Investment Approaches buying stock in marijuana companies

: Gain diversified exposure through funds like the AdvisorShares Pure US Cannabis ETF (MSOS) or the Amplify Alternative Harvest ETF (MJ) to spread risk across multiple growers and ancillary providers. : Rescheduling to Schedule III would eliminate Section

: If federal restrictions are lifted, U.S. operators could move from OTC markets to the NYSE or NASDAQ, significantly increasing institutional capital and liquidity. While the sector has seen a historical valuation

: The entry of large-scale institutional investors is expected to be a primary driver for sustained equity appreciation, transforming the sector from speculative to institutional-grade. Risks and Considerations How to Buy Marijuana Stocks: A Beginner's Guide

: Invest in companies that support the industry without touching the plant, such as Innovative Industrial Properties (IIPR), which provides specialized real estate, or Quest Diagnostics (DGX) for workplace drug testing. Key Market Catalysts for 2026

: Purchase individual shares of Multi-State Operators (MSOs) like Green Thumb Industries (GTBIF) or Trulieve (TCNNF), which often trade on Over-the-Counter (OTC) markets.